ResMed Inc. (RSMDF)
OTCMKTS
· Delayed Price · Currency is USD
27.25
0.00 (0.00%)
At close: Dec 2, 2025
ResMed Revenue
ResMed had revenue of $1.34B in the quarter ending September 30, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.26B, up 9.36% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.
Revenue (ttm)
5.26B
Revenue Growth
+9.36%
P/S Ratio
7.11
Revenue / Employee
495.98K
Employees
10,600
Market Cap
37.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
ResMed News
- 1 day ago - Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed - Nasdaq
- 1 day ago - Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus
- 2 days ago - Should You Continue to Hold RMD Stock in Your Portfolio? - Nasdaq
- 3 days ago - Insider Sell Alert: Brett Sandercock Sells Shares of ResMed Inc (RMD) - GuruFocus
- 4 days ago - ResMed (RMD) Dropped from Goldman Sachs' APAC Conviction List - GuruFocus
- 8 days ago - PETER FARRELL At ResMed Acquires Stock Options Worth $7K - Benzinga
- 8 days ago - Michael J Farrell Makes Strategic Play: Invests $179K In ResMed Stock Options - Benzinga
- 9 days ago - Insider Sell: Witte De Sells 2,055 Shares of ResMed Inc (RMD) - GuruFocus